American Healthcare REIT (NYSE:AHR - Get Free Report) had its price target boosted by investment analysts at Citigroup from $65.00 to $67.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a "buy" rating on the stock. Citigroup's price objective would suggest a potential upside of 13.32% from the company's current price.
Several other research firms also recently weighed in on AHR. Compass Point began coverage on American Healthcare REIT in a research report on Tuesday, July 21st. They set a "buy" rating and a $70.00 price target for the company. Zacks Research raised American Healthcare REIT from a "hold" rating to a "strong-buy" rating in a report on Friday, October 2nd. Weiss Ratings cut American Healthcare REIT from a "buy (b-)" rating to a "hold (c+)" rating in a report on Tuesday, October 6th. Royal Bank Of Canada upped their price objective on American Healthcare REIT from $61.00 to $66.00 and gave the company an "outperform" rating in a research report on Tuesday. Finally, Scotiabank increased their price objective on American Healthcare REIT from $56.00 to $62.00 and gave the company an "outperform" rating in a research note on Wednesday, September 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Buy" and a consensus price target of $63.31.
Check Out Our Latest Stock Report on AHR
American Healthcare REIT Price Performance
Shares of AHR stock traded up $0.16 during trading hours on Tuesday, hitting $59.12. The company's stock had a trading volume of 1,412,225 shares, compared to its average volume of 3,000,163. The business has a fifty day moving average of $53.15 and a 200-day moving average of $51.70. The stock has a market cap of $12.89 billion, a price-to-earnings ratio of 120.78, a P/E/G ratio of 1.38 and a beta of 0.78. American Healthcare REIT has a twelve month low of $44.81 and a twelve month high of $59.53. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 0.24.
American Healthcare REIT (NYSE:AHR - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.56 by $0.02. American Healthcare REIT had a return on equity of 3.63% and a net margin of 4.84%. The firm had revenue of $742.15 million during the quarter, compared to the consensus estimate of $703.51 million. During the same period in the previous year, the firm posted $0.44 EPS. The company's quarterly revenue was up 29.5% compared to the same quarter last year. As a group, equities research analysts anticipate that American Healthcare REIT will post 2.19 EPS for the current year.
Insider Transactions at American Healthcare REIT
In related news, EVP Mark Foster sold 1,500 shares of the firm's stock in a transaction that occurred on Friday, September 25th. The shares were sold at an average price of $52.06, for a total transaction of $78,090.00. Following the sale, the executive vice president owned 50,117 shares in the company, valued at approximately $2,609,091.02. This trade represents a 2.91% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.75% of the company's stock.
Institutional Inflows and Outflows
A number of large investors have recently made changes to their positions in AHR. Outlook Capital Management LLC purchased a new stake in shares of American Healthcare REIT in the second quarter valued at $25,000. Manning & Napier Advisors LLC purchased a new position in American Healthcare REIT during the first quarter worth about $26,000. Silver Grove Financial Group Inc. lifted its position in American Healthcare REIT by 1,065.5% during the third quarter. Silver Grove Financial Group Inc. now owns 641 shares of the company's stock worth $33,000 after buying an additional 586 shares during the period. Covestor Ltd boosted its stake in American Healthcare REIT by 297.8% in the 3rd quarter. Covestor Ltd now owns 720 shares of the company's stock worth $37,000 after buying an additional 539 shares during the last quarter. Finally, Jacobi Capital Management LLC acquired a new stake in American Healthcare REIT in the 3rd quarter worth about $46,000. Hedge funds and other institutional investors own 16.68% of the company's stock.
About American Healthcare REIT
(
Get Free Report)
American Healthcare REIT is a real estate investment trust focused on healthcare-related properties. Its portfolio includes senior housing and care communities, skilled nursing facilities, outpatient medical buildings, and integrated senior health campuses. The company owns and operates properties across the United States and the United Kingdom. Its facilities support a range of healthcare and senior living services, including assisted living, memory care, and post-acute care. American Healthcare REIT began trading on the New York Stock Exchange in 2024.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider American Healthcare REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and American Healthcare REIT wasn't on the list.
While American Healthcare REIT currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.